BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12003824)

  • 1. Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha.
    Funakoshi H; Kubota T; Machida Y; Kawamura N; Feldman AM; Tsutsui H; Shimokawa H; Takeshita A
    Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2159-66. PubMed ID: 12003824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy.
    Funakoshi H; Kubota T; Kawamura N; Machida Y; Feldman AM; Tsutsui H; Shimokawa H; Takeshita A
    Circ Res; 2002 May; 90(9):959-65. PubMed ID: 12016261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative.
    Naka M; Nanbu T; Kobayashi K; Kamanaka Y; Komeno M; Yanase R; Fukutomi T; Fujimura S; Seo HG; Fujiwara N; Ohuchida S; Suzuki K; Kondo K; Taniguchi N
    Biochem Biophys Res Commun; 2000 Apr; 270(2):663-7. PubMed ID: 10753680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure.
    Gealekman O; Abassi Z; Rubinstein I; Winaver J; Binah O
    Circulation; 2002 Jan; 105(2):236-43. PubMed ID: 11790707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
    Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
    J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice.
    Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T
    Eur J Pharmacol; 2001 Jan; 412(1):91-9. PubMed ID: 11166740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.
    Satoh M; Nakamura M; Tamura G; Makita S; Segawa I; Tashiro A; Satodate R; Hiramori K
    J Am Coll Cardiol; 1997 Mar; 29(4):716-24. PubMed ID: 9091515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes.
    Ashley EA; Sears CE; Bryant SM; Watkins HC; Casadei B
    Circulation; 2002 Jun; 105(25):3011-6. PubMed ID: 12081996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a selective inhibitor of inducible nitric oxide synthase, ONO-1714, on experimental hemodialysis-related hypotension in renal dysfunctional dogs.
    Komeno M; Akimoto A; Fujita T; Katsube N
    J Pharmacol Sci; 2004 Nov; 96(3):343-6. PubMed ID: 15539758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
    Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
    Liu H; Ma Z; Lee SS
    Gastroenterology; 2000 May; 118(5):937-44. PubMed ID: 10784593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction.
    Heger J; Gödecke A; Flögel U; Merx MW; Molojavyi A; Kühn-Velten WN; Schrader J
    Circ Res; 2002 Jan; 90(1):93-9. PubMed ID: 11786524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.
    Okamoto I; Abe M; Shibata K; Shimizu N; Sakata N; Katsuragi T; Tanaka K
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):716-22. PubMed ID: 10934111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.
    Barouch LA; Harrison RW; Skaf MW; Rosas GO; Cappola TP; Kobeissi ZA; Hobai IA; Lemmon CA; Burnett AL; O'Rourke B; Rodriguez ER; Huang PL; Lima JA; Berkowitz DE; Hare JM
    Nature; 2002 Mar; 416(6878):337-9. PubMed ID: 11907582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
    Brunner F; Andrew P; Wölkart G; Zechner R; Mayer B
    Circulation; 2001 Dec; 104(25):3097-102. PubMed ID: 11748107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
    Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
    Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
    J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
    Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
    J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury.
    Jones SP; Greer JJ; Kakkar AK; Ware PD; Turnage RH; Hicks M; van Haperen R; de Crom R; Kawashima S; Yokoyama M; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H276-82. PubMed ID: 12969888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.
    Gaballa MA; Raya TE; Hoover CA; Goldman S
    Cardiovasc Res; 1999 Jun; 42(3):627-35. PubMed ID: 10533602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.